Other languages Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
21.33 ^USD	+1.86%		+1.62%	+47.92%

May. 24	Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation	MT
May. 24	Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation	May. 24
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14	May. 24
Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14	May. 24
Organon & Co and Organon Foreign Debt Co-Issuer B.V Closes Their Previously Announces Private Offering of $500 Million of 6.750% Senior Secured Notes Due 2034 and $500 Million of 7.875% Senior Unsecured Notes Due 2034	May. 17
Organon Reports Pricing of $1 Billion Senior Notes Offering	May. 08
Organon Announces Pricing of $1.0 Billion Senior Notes Offering	May. 07
Organon & Co. and Organon Foreign Debt Co-Issuer B.V. Announces Pricing of $1.0 Billion Senior Notes Offering	May. 07
Organon Plans Offerings of Secured, Unsecured Senior Notes Totaling $1 Billion	May. 07
Organon Announces Proposed $1.0 Billion Senior Notes Offering	May. 07
Organon & Co. and Organon Foreign Debt Co-Issuer BV Announces Proposed $1.0 Billion Senior Notes Offering	May. 07
Organon : Q1 2024 Transcript	May. 03
Organon's Q1 Adjusted Earnings, Revenue Rise; 2024 Revenue Guidance, Quarterly Dividend Maintained	May. 02
Organon : Q1 2024 Earnings Presentation	May. 02
Organon : 2024 Annual Meeting of Shareholders	May. 02
Transcript : Organon & Co., Q1 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (OGN) ORGANON & CO. Reports Q1 Revenue $1.62B, vs. Street Est of $1.56B	May. 02
Organon: Q1 Earnings Snapshot	May. 02
Earnings Flash (OGN) ORGANON & CO. Reports Q1 EPS $1.22, vs. Street Est of $0.93	May. 02
Organon Reports Results for the First Quarter Ended March 31, 2024	May. 02
Organon & Co. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Organon & Co.

Equities

OGN

US68622V1061

Other languages

Filters